Latest News
Treatment of Ruptured GIST Outside of Gastrointestinal Tract: A Case Study
Artificial Intelligence Could Help Diagnose GIST
New Photoshop Technique Used to Distinguish GIST From Leiomyomas
New Study Findings Could Guide Therapeutic Approaches for Duodenal GISTs
CT Radiomics Can Predict Recurrence-Free Survival in Patients With GISTs
Significant Muscle Loss During GIST Therapy Associated With Worse Prognosis
Fluorine-Labeled FAPI-42 PET/CT Detects More GISTs Than FDG PET/CT
Noninvasive Radiomics Can Evaluate Malignancy Risk in GIST
Trial Testing Potential GIST Treatment Now Recruiting Patients
Latest Clinical Trials
Insights
The Multifaceted Challenges of Treating GIST in Pediatric Patients
There are a few major hurdles physicians have to navigate when treating pediatric patients with gastrointestinal stromal tumors.
Can Artificial Intelligence Be Used to Predict Malignant Potential in GIST?
Artificial intelligence has been shown to have good predictive value for the malignant potential of gastrointestinal stromal tumors.
Beyond Imatinib: Next-Generation TKIs for the Treatment of GIST
Recently developed TKIs such as ripretinib and avapritinib have the potential to change the treatment landscape of GIST.
Diagnosing GIST Preoperatively: Challenges and Advantages
Various studies have analyzed how to better diagnose gastrointestinal stromal tumors at the preoperative stage.
Patient Perspectives
A GIST Patient’s Journey: A Quest to be Heard
When diagnosed with a gastrointestinal stromal tumor (GIST) or any rare disease, the patient usually sees a doctor specializing in the treatment of that disease. Unfortunately, I live on a rock in the middle of the ocean, which makes finding the right doctor especially difficult.
Help GIST Patients Find Their New Normal
Many cancer patients would disagree, but GIST cancer has been both the best and worst thing that has ever happened to me.
A Frontline View: A Clinical Trial For Pediatric and Wildtype (SDHA) GIST
Three years ago, I heard one of the many things a cancer patient does not want to hear, “You have new growths. You’ve relapsed.” It was the first time I cried because of my cancer diagnosis, reality finally hit, and I was devastated. Relapsing with pediatric and wildtype (SDHA) gastrointestinal stromal tumor (GIST) was hard…
GIST Features
‘Fundamental Flaws’ Plague Drug Development Process, Ultragenyx CEO Dr. Emil Kakkis Says
Ultragenyx CEO Dr. Emil D. Kakkis said federal regulators should focus more on biomarkers and less on clinical endpoints when it comes to drug approvals.
Using Deep Learning to Predict Risk in Gastrointestinal Stromal Tumors
Deep learning is now used to detect disease or abnormalities from x-ray images and classify them into several disease types or severities in radiology.
New Advances in the Radiomics of Gastrointestinal Stromal Tumors
It has been shown that radiomic features may be useful for predicting patient survival, treatment response, and metastatic potential of tumors.
Israel Emerges as Global Powerhouse in Rare Disease Research
When it comes to rare disorders, Israel—a New Jersey-sized nation of 9.3 million that’s made headlines this year for its highly successful coronavirus vaccination campaign—is clearly an emerging powerhouse.
Rare Care Podcast
Advocating for People With Gastrointestinal Stromal Tumor: An interview with Peter Knox, senior research director at the Life Raft Group
- Loading...
Loading...
Loading... 
Loading...